Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › About Us › Our Staff › staff reporter

staff reporter

Email
[email protected]

Articles Authored by staff reporter

Apr 16, 2021

In Brief This Week: Amgen, BC Platforms, Siemens Healthineers, Agilent

News items for the week of April 12, 2021. 

Apr 16, 2021

PanCAN Begins Study Screening Diabetes Patients for Early Signs of Pancreatic Cancer

PanCAN has invested $25 million in the study, which will screen blood samples from new-onset diabetes patients for biomarkers associated with pancreatic cancer.

Apr 15, 2021

Cancer Dx Firm C2i Genomics Raises $100M in Financing

The company will use the funds to accelerate the clinical development and commercialization of its minimal residual disease detection C2-Intelligence Platform.

Apr 15, 2021

Ideaya Biosciences Begins Phase I Trial of MAT2A Inhibitor in Tumors With MTAP Deletion

The trial will identify patients using NGS and an IHC assay, which Ideaya and Ventana codeveloped to confirm MTAP protein levels.

Apr 15, 2021

OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer

The French cancer center will use OncoDNA's blood-based next-generation sequencing test, OncoFollow, in its ongoing SCANDARE study.

Apr 15, 2021

Flagship Biosciences, Leap Therapeutics Partner on Biomarker Screening for DKN-01 Clinical Trial

Flagship will use its RNAscope assay and image analysis to screen advanced gastric and gastroesophageal cancer patients for elevated DKK1 RNA expression.

Apr 15, 2021

NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker Study

The team will use NanoView's ExoView platform to characterize PD-L1 and other biomarkers carried by exosomes in plasma samples from patients undergoing therapy.

Apr 14, 2021

Tango Therapeutics to Go Public on Nasdaq Through SPAC

The combined company is expected to receive $353 million in gross proceeds, which will help advance several of Tango's precision oncology drug candidates.

Apr 14, 2021

AstraZeneca's Tagrisso Approved in China for Adjuvant Treatment of EGFR-Mutated NSCLC

The approval from China's National Medical Products Administration expands access to the drug in a country with a significant lung cancer burden.

Apr 13, 2021

Theseus Pharmaceuticals Emerges from Stealth Mode, Raises $100M in Series B Funding

The company's pipeline includes a KIT inhibitor that will move into clinical studies this year and an EGFR inhibitor in preclinical studies.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.